Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed trials have results

Key Signals

Enrollment reporting

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT06499701Completed

Volume Kinetics of Fluid Resuscitation in Early Sepsis

Role: lead

NCT07676786Not Yet Recruiting

Euvolemia-Based Assessment of Pulmonary Hypertension in Stable Hemodialysis Patients

Role: collaborator

NCT06814561Completed

Hemodynamic Determinants of Urine Output During Spinal Anesthesia

Role: lead

NCT06696781Completed

NOL Index in Response to Pacemaker Stimulation

Role: lead

NCT06582368Completed

Determinants of Portal Vein Pulsatility Index

Role: lead

NCT06440772Completed

Portal Vein Pulsatility Index to Assess Fluid Intolerance

Role: lead

NCT06474052Completed

Volume Kinetics of Gelofusine 4% During Vascular Surgery

Role: lead

NCT06070701Not ApplicableCompleted

NOL-Guided Superficial Parasternal Intercostal Plane Block Versus Erector Spinae Plane Block

Role: lead

NCT04338984Phase 4Completed

Nociception-directed Erector Muscle Spinae Plane Block in Open Heart Surgery

Role: lead

NCT04582838Completed

Photoplethysmographic Scaling of Dyspnoea

Role: lead

All 10 trials loaded